Overview of Dalun

What is Dalun? Defining the Medicine’s Identity

Property	Description
Active ingredient	Hydroxyzine
Form	Tablet, Capsule, Syrup, Injection Solution
Pharmacological class	First-Generation Antihistamine
Common use	Calming/Anxiety, Itching (Pruritus)
Origin	Synthetic Compound

What Type of Medicine is Dalun (Hydroxyzine)?

Dalun is a prescription-only pharmaceutical preparation that contains the single active substance Hydroxyzine (typically as the hydrochloride salt). This compound is chemically defined as a piperazine derivative, and it is a first-generation antihistamine. This pharmacological positioning is clinically recognized for its capacity to produce central nervous system effects, a key differentiating factor from newer anti-allergic agents. As a synthetic compound, Hydroxyzine's core molecule is manufactured for consistent properties and is formulated for systemic administration in multiple dosage forms, including oral tablets, syrups, and sterile solutions for injection.

General Purpose: Is Dalun Used for Calming or Itching?

The general therapeutic purpose of Dalun is defined by its two principal actions: antipruritic (anti-itch) and anxiolytic-sedative (calming). Its potent anti-histamine effect is utilized to alleviate widespread itching, or pruritus, by interrupting the body's histamine response. Concurrently, the substance readily crosses the blood-brain barrier, resulting in a central nervous system depressant effect. This characteristic provides a calming influence, which is why it is often employed for the symptomatic management of general tension and mild anxiety. This dual positioning allows for managing agitation while addressing histamine-mediated symptoms.

Composition and Chemical Origin

Dalun is manufactured as a single-ingredient product, centered around the molecule Hydroxyzine. The core active constituent is a synthetic compound which is combined with standard aqueous or non-aqueous pharmaceutical vehicles and inactive excipients necessary to ensure the medicine's stability and effective absorption for systemic administration. This defined composition is consistent across all its available forms for reliable therapeutic delivery.

Regulatory References

What side effects are possible with Dalun?

The possible side effects and safety characteristics of Dalun (Hydroxyzine) are classified by frequency and system-organ class in official regulatory documents.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their documented occurrence rates. Sedation or Somnolence is classified as Very Common. Effects listed as Common include dry mouth, headache, and fatigue. Less frequent effects (Uncommon or Rare) involve various systems, such as dizziness, insomnia, tremor, confusion, tachycardia, urinary retention, and hypersensitivity reactions. The official labels also list reactions where the frequency cannot be estimated from available data, including QT interval prolongation and Ventricular fibrillation.

Serious Adverse Reactions

The most significant documented safety concern involves the potential for QT interval prolongation on the electrocardiogram, which can lead to life-threatening heart rhythm abnormalities, such as Torsade de Pointes. Other serious, though Very Rare, reactions include Anaphylactic shock and severe skin conditions like Acute Generalized Exanthematous Pustulosis (AGEP).

Population-Specific Safety Notes

The medicine is subject to specific constraints based on population. Older adults are noted in regulatory texts to have an increased susceptibility to central nervous system effects (e.g., confusion) and a heightened risk of QT prolongation. Dose adjustments are often mandated for patients with known hepatic or renal impairment due to reduced clearance and the potential for increased systemic exposure. Use is often contraindicated in early pregnancy.

Safety-Related Restrictions

Use of the medicine is formally contraindicated in individuals with a known history of QT interval prolongation or other risk factors for heart rhythm disturbances, such as certain cardiovascular diseases or significant electrolyte imbalances. The potentiating action of Hydroxyzine must also be considered when co-administered with other central nervous system depressants, which can increase the risk of drowsiness or other CNS effects.

Overdose and Emergency Response

The official regulatory profile for Dalun overdose centers on two major physiological concerns: the Central Nervous System (CNS) and the Cardiovascular System. The most frequent manifestation of an overdose is hypersedation, which may progress to stupor or loss of consciousness. Paradoxically, signs of CNS excitement, such as tremor or convulsions (seizures), have also been reported, with younger children being noted as more susceptible to CNS stimulation. Officially documented anticholinergic effects like dry mouth and urinary retention may also present.

Regulators mandate that individuals must seek immediate medical attention for any suspected overdose. This requirement is especially critical if severe symptoms like palpitations, trouble breathing, or loss of consciousness are observed. There is no specific antidote known for Dalun overdose.

Management procedures detailed in official labeling include immediate gastric lavage if vomiting has not occurred spontaneously, and the provision of general supportive care. Continuous ECG monitoring is recommended due to the possibility of QTc prolongation, which is a key cardiovascular risk along with the potential for Torsade de Pointes. The official guidance also specifies that epinephrine should not be used to manage hypotension in this setting due to documented pharmacological conflict.

Therapeutic Uses of Dalun

The therapeutic utility of Dalun is relevant across clinical domains involving heightened patient distress or symptoms associated with acute or episodic changes. Dalun is used as part of symptomatic management to help manage both allergic and emotional symptoms where short-term symptomatic assistance is appropriate.

Dalun is commonly used to help manage symptoms in conditions characterized by periods of heightened symptoms, including intense, widespread itching (pruritus), generalized nervous tension, and pre-procedural anxiety.

“The medication offers supportive relief and contributes to improved comfort during periods when symptoms are more noticeable.”

Symptomatic Relief and Calming Support

This medication is applied in addressing symptom clusters that may become intense or disruptive, such as the severe physical discomfort of allergic skin itching, inner restlessness, or symptoms related to increased discomfort or tension. Its use in these settings helps ease the overall symptom burden, and the resulting calming effect supports the patient during difficult episodes by easing distress. In specific clinical scenarios, such as before medical procedures, Dalun may be part of symptomatic management to help promote a sense of relaxation and assist with maintaining comfort.

Quick Fact: Relief for Pruritus and Tension Dalun is commonly used when symptoms of moderate-to-severe itching or nervous tension create noticeable functional strain, offering symptomatic relief to help patients cope more steadily with symptom fluctuations.

Regulatory References

European Medicines Agency therapeutic overview

Eligibility and Restrictions for Use

The official regulatory profile for Dalun (Hydroxyzine) defines strict rules for patient eligibility based on cardiac safety, hypersensitivity, and physiological status.

Who Must Not Use Dalun (Contraindications)

Prolonged QT Interval: Use is absolutely prohibited in patients with a congenital or acquired prolonged QT interval due to a significant cardiovascular risk.
Hypersensitivity: Contraindicated for individuals with a known allergy to Dalun (Hydroxyzine), Cetirizine, Levocetirizine, or any component of the formulation.
Early Pregnancy: Use is contraindicated during early pregnancy because clinical data are inadequate to establish safety.

Populations Requiring Conditional or Restricted Use

Age Limits: The medicine is approved for use in adults and pediatric patients (children under 6 and 6 years and older). Use in older adults (geriatric) is generally not recommended or requires cautious, low-dose selection due to reduced drug elimination.
Organ Function: Patients with decreased hepatic, renal, or cardiac function require cautious dose selection, reflecting the greater frequency of these impairments.
Cardiovascular Risk: Use requires caution in patients with risk factors for QT prolongation, such as recent myocardial infarction or uncompensated heart failure.
Lactation: Dalun is not recommended for nursing or breastfeeding mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Medicines and other products can sometimes affect how Dalun works in the body, or Dalun may affect how other co-administered products function. These drug-drug interactions (DDIs) can change the concentration of one or both substances in the bloodstream, which may alter their effects.

Enzyme-Mediated Interactions: Some of the most common mechanisms for DDIs involve enzymes and transporters in the body, particularly the Cytochrome P450 (CYP) enzyme family. Products that strongly induce (speed up) or inhibit (slow down) these enzymes, such as CYP3A4, may alter Dalun's systemic exposure. This could potentially increase the risk of side effects if concentrations become too high, or reduce the medicine's effectiveness if concentrations become too low.
Pharmacodynamic Interactions: Interactions can also occur when two medicines have similar effects on the body, leading to an exaggerated response. For example, combining Dalun with other products that cause a certain effect may increase the severity of that effect.
Interaction Context and Classification: Official regulatory documents identify specific interacting medicinal products and product classes, classifying combinations by clinical significance (e.g., contraindicated, requiring caution/monitoring, or having no clinically relevant interaction). These documents provide essential guidance on necessary dosage adjustments, spacing requirements, or the need to avoid certain combinations entirely.

Before taking Dalun, it is important to provide a complete list of all currently used prescription medicines, over-the-counter products, and dietary or herbal supplements to a healthcare provider. They will evaluate for potential interactions that could affect Dalun’s safety or efficacy.

Mechanism of Action

Molecular Mechanism: Competitive Blockade of the Histamine H1 Receptor

Dalun's primary mechanism involves the molecule acting as a competitive antagonist with demonstrated receptor affinity at the Histamine H1 receptor across both the central and peripheral nervous systems. This blockade suppresses the signaling that would normally be initiated by endogenous histamine, thereby modifying early molecular steps that shape systemic physiological outcomes.

Central Action: Modulation of Subcortical Arousal Centers

Due to its ability to readily cross the blood-brain barrier, Dalun targets and inhibits activity within key subcortical structures, including the Limbic System and the Reticular Activating System. This action engages mechanisms that modulate activity in neural processes, leading to a reduction in central neural excitability.

Polypharmacology: Secondary Action on Muscarinic and Serotonin Pathways

The drug also modulates activity within other specific receptor systems by blocking the Muscarinic Acetylcholine receptor (M1 subtype) and the Serotonin 5-HT2A receptor. This secondary activity influences autonomic tone and central transmission within targeted pathways, though the mechanism is constrained by physiological processes not driven by histamine.

Dosage and Administration Information

How Dalun (Hydroxyzine) Is Used: Administration Guidelines

Dalun, containing the active substance hydroxyzine, is administered according to established protocols to ensure proper usage. The medicine is available for oral intake (as tablets, capsules, or syrup) and for Intramuscular (IM) injection as a sterile solution, with the injection form being prohibited for intravenous or subcutaneous administration.

Standard Dosing and Frequency

Indication	Adult Dosing Regimen	Frequency Pattern
Anxiety/Tension	Typically 50 mg to 100 mg per dose	Administered in three or four divided doses (t.i.d. or q.i.d.)
Pruritus (Itching)	Typically 25 mg per dose	Administered in three or four divided doses (t.i.d. or q.i.d.)
Pre-Procedural Sedation	Single dose of 50 mg to 100 mg IM	Single administration

Daily intake has maximum limits that must not be exceeded. General guidelines restrict the maximum total adult daily dose to 100 mg/day, whereas the maximum dose for geriatric patients is limited to 50 mg/day.

Special Administration Requirements

For pediatric patients, the dosage is calculated based on age and body weight and is administered in divided doses. When initiating therapy, the dose for older adults is typically initiated at the lower end of the dosing range. For liquid oral forms, the instruction is to shake the container well before measurement to ensure a consistent dose. When the medication is given via the IM route, it is injected deeply into a large muscle mass to comply with administration constraints. The need for continued use is periodically reassessed for treatments extending beyond four months.

Recent Clinical Evidence

Research evidence / Overview of Studies for Dalun

Research examined Dalun's use in the context of general tension and for symptomatic relief of itching. Research has explored how symptoms change over defined time intervals in observed populations, and the available evidence contributes to the understanding of Dalun's short-term symptomatic patterns.

Evidence for Use in Managing Generalized Anxiety and Tension

Research for Dalun in the context of general tension and anxiety primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were conducted on adult patients to understand patterns related to symptoms that reflect systemic or functional imbalance. Researchers monitored changes in anxiety symptom severity using established rating scales, such as the Hamilton Rating Scale for Anxiety (HAM-A), and assessed patient-reported outcomes describing perceived discomfort and overall status. Findings describe patterns observed in the studies, which often monitored changes over time intervals of between 4 and 12 weeks. What remains uncertain is the long-term characterization of Dalun's use. Follow-up durations were limited in the controlled studies, meaning there is limited information for long-term outcomes.

Evidence for Use in Symptomatic Relief of Pruritus (Itching)

Research examined Dalun in conditions associated with acute or disruptive episodes of itching, or pruritus, particularly those linked to inflammatory or irritative states. The evidence includes both controlled trials and observational studies. Studies examined changes measured during the study period, such as itch severity scores and patient-reported Quality of Life (QoL) indices. The research describes short-term changes in symptoms for people experiencing periods of heightened symptom activity due to allergic or dermatological causes. Research for outcomes related to certain groups or forms of chronic itching not directly related to a histamine response remains limited. Research exploring short-term symptom changes exists, and the evidence contributes to understanding symptom patterns primarily over short- to medium-term periods, typically up to 12 weeks.

Long-Term Studies and Durability of Effect

The evidence landscape highlights that the research conducted for both anxiety and itching has limited information for long-term outcomes. The majority of controlled research was designed for short-term durations (typically up to 12 weeks or 4 months). Evidence related to whether observed changes are maintained over extended periods is not fully established, meaning certainty remains low regarding its use for long-term maintenance of effect.

Evidence in Specific Patient Populations

Research was evaluated in different age groups, including adults, children, and older adults. This research has explored Dalun in different age groups to examine potential differences in measured outcomes. Pediatric Populations: Dalun was studied for potential use in children; however, available data for pediatric populations remain insufficient. Older Adults: Older adults represent a group where research has focused on understanding potential differences in measured outcomes, and data for this specific group remain insufficient.

Key Studies & References

Hydroxyzine as a pre-operative sedative: a double blind study with apprehensive children

Frequently Asked Questions (FAQ)

Common questions about Dalun (FAQ)

Q: Does Dalun help with inflammation?

As an antihistamine, Dalun's primary function is to block the body’s response to histamine. This mechanism is linked to a reduction of symptoms like itching that may be associated with inflammatory or irritative conditions. However, regulatory documents describe its main use as antipruritic (anti-itch) and calming, not specifically as an anti-inflammatory drug.

Q: Are there any long-term effects of taking Dalun?

Studies and official documents indicate that the effectiveness and safety of Dalun have not been systematically assessed for long-term use, defined as use extending beyond four months. Due to this limitation, periodical reassessment by a healthcare provider may be recommended in the official prescribing information.

Q: Can women who are pregnant or breastfeeding use Dalun?

According to official product information, Dalun is often contraindicated (not recommended) in early pregnancy. Regarding breastfeeding, use is generally not advised because the active ingredient can be transferred through breast milk, potentially causing drowsiness or other effects in the nursing infant.

Q: Does Dalun affect mood or cause anxiety?

Dalun is authorized for managing symptoms of anxiety and tension due to its calming properties. However, official safety data also notes rare psychiatric side effects such as confusion, hallucinations, and irritability in post-marketing experience.

Q: If I feel better, can I stop taking Dalun early?

The official product information states that the need for continued treatment should be periodically reassessed by a healthcare provider. While not typically associated with severe physical withdrawal, any decision to stop the medication, even if a person feels better, is a decision that should be discussed with a healthcare provider.

Q: Why does the official document warn against using Dalun with [Specific class of drug]?

Warnings are issued because Dalun can interact with certain other medicines in two main ways. Combining it with other central nervous system (CNS) depressants may increase the risk of side effects like excessive drowsiness. Additionally, combining it with drugs known to prolong the QT interval can increase the risk of serious heart rhythm abnormalities.

Q: How quickly can I expect to notice any difference after starting Dalun?

Studies indicate that the effects of Dalun are usually noted relatively quickly after the oral dose, typically within 15 to 30 minutes. The active ingredient generally reaches its highest concentration in the bloodstream in about two hours.

Q: Why does Dalun need to be taken consistently?

Regulatory guidance defines that Dalun is to be taken in multiple divided doses throughout the day (e.g., three or four times daily). This consistent frequency is intended to maintain a stable concentration of the active ingredient in the bloodstream over time.

Q: What happens if I miss a single dose of Dalun?

Official regulatory guidance advises that if a single dose is missed, it should be taken as soon as it is remembered unless it is almost time for the next scheduled dose. If it is close to the next dose, the guidance advises skipping the missed dose and returning to the regular schedule. The official guidance also states that dosing should not be doubled to compensate.

Q: Does Dalun interact with caffeine or energy drinks?

Although not strictly prohibited in regulatory documents, products containing caffeine or other stimulants may work against Dalun’s sedative effect. If Dalun is being used for anxiety or to promote sleep, the calming effect of the medication may potentially be reduced by stimulants.

Q: Can I take simple pain relievers (like ibuprofen or acetaminophen) while on Dalun?

Official patient information recommends providing a full list of all over-the-counter products to a healthcare provider. There is generally considered a low potential for interaction between Dalun and common non-opioid pain relievers like ibuprofen, but consultation with a medical professional is required to evaluate individual risk.

Q: Are there any specific foods I should avoid when using Dalun?

According to the official product information, Dalun can generally be taken with or without food. Regulatory documents do not list any specific foods that must be avoided while using this medication.

Q: How long after stopping Dalun does it stay in my system?

Studies examining the pharmacokinetics (how the body handles the drug) report that the active ingredient in Dalun has a mean elimination half-life of approximately 20 hours in adults. This means it takes approximately that long for the concentration in the body to be reduced by half.

Q: Is Dalun addictive or habit-forming?

Dalun is not listed as a controlled substance under federal law in the United States. Due to this official classification, it is not generally considered to have the potential for abuse or habit-forming effects.

Q: Can Dalun be crushed or split if a patient has trouble swallowing?

Dalun tablets are not typically extended-release formulations. However, to ensure a person receives the correct dose, splitting or crushing of tablets is a decision that should only be made following specific instruction from a healthcare provider or pharmacist to ensure proper dosage.

Q: Does Dalun have a Black Box Warning?

The official label for Dalun does not explicitly carry a formal Black Box Warning designation as a separate warning header. However, regulatory documents do highlight the potential for serious heart rhythm issues, specifically QT prolongation, in bold text to ensure awareness of this significant safety concern.

Q: Does Dalun interact with alcohol?

Official regulatory documents contain statements about avoiding or strictly limiting the consumption of alcohol while taking Dalun. This is because alcohol can significantly increase the central nervous system side effects of the drug, potentially leading to excessive drowsiness and impaired concentration.

Q: Is Dalun a Schedule V controlled substance?

Dalun is not classified as a controlled substance under federal law, meaning it does not fall under any of the schedules (I-V) used to regulate drugs with potential for abuse or dependence.

How should Dalun be stored and disposed of?

Storage and Stability

Dalun (Clindamycin Capsules placeholder) must be stored below a temperature threshold, typically 25 C or 30 C, depending on the specific product label. The medicine must be kept in its original container and protected from heat, light, and moisture. To maintain stability, the capsules should not be stored in damp locations, such as a bathroom, or exposed to direct sunlight.

Child Safety and Handling

It is mandatory to store this medicine out of the sight and reach of children in a secure, elevated location, such as a locked cupboard. Do not use the medicine past the expiration date printed on the packaging.

Disposal Instructions

Unused or expired Dalun must be disposed of according to local regulatory requirements. The medicine should be returned to a pharmacy or utilized in an official drug take-back program where available. It is strictly advised not to dispose of the medicine by flushing it down the toilet or pouring it down the sink, as this may contaminate the environment.

Dalun